Thursday, June 8, 2017
- 1:15pm-2:45pm
-
Double-blind, randomized, placebo-controlled, Phase III study (TOLEDO) to evaluate the efficacy of apomorphine subcutaneous infusion in reducing OFF time in Parkinson’s disease patients with motor fluctuations not well controlled on optimized conventional treatment
Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C
- 1:15pm-2:45pm
-
Drug utilization characteristics in individuals with early Parkinson’s disease interim analysis of the STEADY-PD III study
Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C
- 1:15pm-2:45pm
-
Dystonia due to bilateral caudate hemorrhage associated with a COL4A1 mutation
Dystonia · Exhibit Hall C
- 1:15pm-2:45pm
-
Dystonia Gravidarum Improved After Joint Position Error Training
Dystonia · Exhibit Hall C
- 1:15pm-2:45pm
-
Dystonia treatment in an international cohort: a longitudinal analysis
Dystonia · Exhibit Hall C
- 1:15pm-2:45pm
-
Dystonia-like phenotype in a DYT1 rat model after peripheral trauma
Dystonia · Exhibit Hall C
- 1:15pm-2:45pm
-
Early caudate involvement in Parkinson’s disease may predict future cognitive decline
Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C
- 1:15pm-2:45pm
-
Early cognitive impairment phenotype and functional connectivity in non-demented Parkinson’s disease patients
Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C
- 1:15pm-2:45pm
-
Early morning OFF problems are common in PD patients attending a routine clinical appointment
Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C
- 1:15pm-2:45pm
-
EEG Markers for Emotional Inhibition in Parkinson’s Disease
Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C
- «Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 41
- Next Page»